Charcot foot in diabetes can begin with a warning sign that seems almost contradictory: a foot that is hot, red, and swollen but causes surprisingly little pain. For people with diabetic peripheral neuropathy, reduced sensation may hide the severity of the problem. As a result, patients may continue walking on …
Read More »The Diabetes Organ Nobody Talks About: Could Bone Hold the Next Treatment Breakthrough?
When most people think about diabetes, they picture the pancreas, insulin, or blood sugar. However, researchers are increasingly asking a different question: what if another organ has been quietly influencing glucose metabolism all along? Surprisingly, the answer may be the skeleton. For decades, bone was viewed primarily as the body’s …
Read More »Diabetes and Fracture Risk: Why Bone Health Is Becoming a Bigger Clinical Concern
People living with diabetes already face challenges related to blood sugar, cardiovascular disease, kidney health, and nerve damage. However, another issue is now gaining attention among healthcare professionals: bone health. Research continues to show that patients with diabetes have a higher risk of fractures, falls, and long-term mobility problems, even …
Read More »Do GLP-1 Drugs Improve Osteoarthritis Outcomes? What New Trials Suggest About Pain and Mobility
For many patients with obesity-related osteoarthritis, daily movement can feel like walking with a heavy backpack that never comes off. Joint pain limits exercise, reduced activity leads to more weight gain, and the cycle continues. However, new research is raising an important question: could GLP-1 therapies help break that cycle? …
Read More »GLP-1s and Inflammatory Arthritis: What Early Signals Mean for Diabetes Care
A patient with type 2 diabetes finally achieves better glycemic control on a GLP-1 receptor agonist. Weight is coming down, A1C is improving, and cardiovascular risk looks more manageable. Then an unexpected comment appears at a follow-up visit. Their joints feel better. For clinicians, moments like this raise an important …
Read More »GLP‑1s and Bone Health: Do Incretins Protect or Put Patients at Risk?
Glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have transformed type 2 diabetes management by improving blood sugar control and promoting weight loss. Yet as clinical use grows, so does interest in how GLP‑1 medications affect skeletal health — particularly their impact on bone density, remodeling, and fracture risk. This article unpacks …
Read More »Diabetes and Bone Health: Understanding the Risk of Osteoporosis
Diabetes is a chronic condition that affects many people around the world. While it is well known that diabetes can lead to a range of health complications, many people don’t realize the risks it poses to their bone health. Osteoporosis is a common concern for those living with diabetes, but …
Read More »Insulin Omission for Weight Loss in a Female Adolescent Treated With Advanced Hybrid Closed-Loop System
In a recent article published in the journal Diabetes Care, researchers from Israel reported on a case of a female adolescent with type 1 diabetes who was intentionally omitting insulin in an attempt to lose weight. The adolescent was treated with an advanced hybrid closed-loop system (AHCL), which is a …
Read More »Diabetes May Lead to an Increased Risk of Sarcopenia
Patients with T2DM may be at an increased risk of lower muscle performance and strength, putting them at risk for developing sarcopenia.
Read More »Fractures and Diabetes in African American and Hispanic Patients
African Americans and Hispanics are at increased risk for many diabetes complications; are fractures among them?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.